BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8403793)

  • 1. Effect of glucocorticosteroid treatment on beta-adrenoceptor subtype function in adipocytes from patients with asthma.
    Reynisdottir S; Wahrenberg H; Bylin G; Arner P
    Clin Sci (Lond); 1993 Aug; 85(2):237-44. PubMed ID: 8403793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
    Hellström L; Wahrenberg H; Reynisdottir S; Arner P
    J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
    Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
    Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
    Hoffstedt J; Arner P; Hellers G; Lönnqvist F
    J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
    Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
    J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function.
    Hoffstedt J; Iliadou A; Pedersen NL; Schalling M; Arner P
    Br J Pharmacol; 2001 Jul; 133(5):708-12. PubMed ID: 11429395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
    Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
    Hellmér J; Marcus C; Sonnenfeld T; Arner P
    J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells.
    Rydén M; Faulds G; Hoffstedt J; Wennlund A; Arner P
    Diabetes; 2002 May; 51(5):1601-8. PubMed ID: 11978662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a functional beta 3-adrenoceptor in man.
    Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
    Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
    J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal responsiveness of superficial hand veins to alpha- and beta-adrenergic stimuli in allergic asthma: effects of terbutaline and prednisolone on beta-adrenergic responsiveness.
    Eichler HG; Blöchl-Daum B; Eichler I; Wolzt M; Korn A; Götz M
    J Allergy Clin Immunol; 1990 Nov; 86(5):714-25. PubMed ID: 1977786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
    Germack R; Starzec AB; Vassy R; Perret GY
    Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucocorticosteroid treatment on glucocorticoid receptor expression in human adipocytes.
    Brönnegård M; Reynisdottir S; Marcus C; Stierna P; Arner P
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3608-12. PubMed ID: 8530607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
    Barbe P; Galitzky J; De Glisezinski I; Riviere D; Thalamas C; Senard JM; Crampes F; Lafontan M; Berlan M
    J Clin Endocrinol Metab; 1998 Feb; 83(2):619-25. PubMed ID: 9467583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.